journal article·2024-12Open access

A bioengineered tumor matrix-based scaffold for the evaluation of melatonin efficacy on head and neck squamous cancer stem cells

Julia López de Andrés, César Rodríguez-Santana, Laura de Lara-Peña, Gema Jiménez, Germaine Escames, Juan Antonio Marchal

Abstract

Head and neck squamous cell carcinoma (HNSCC) presents a significant challenge worldwide due to its aggressiveness and high recurrence rates post-treatment, often linked to cancer stem cells (CSCs). Melatonin shows promise as a potent tumor suppressor; however, the effects of melatonin on CSCs remain unclear, and the development of models that closely resemble tumor heterogeneity could help to better understand the effects of this molecule. This study developed a tumor scaffold based on patient fibroblast-derived decellularized extracellular matrix that mimics the HNSCC microenvironment. Our study investigates the antitumoral effects of melatonin within this context. We validated its strong antiproliferative effect on HNSCC CSCs and the reduction of tumor invasion and migration markers, even in a strongly chemoprotective environment, as it is required to increase the minimum doses necessary to impact tumor viability compared to the non-scaffolded tumorspheres culture. Moreover, melatonin exhibited no cytotoxic effects on healthy cells co-cultured in the tumor hydrogel. This scaffold-based platform allows an in vitro study closer to HNSCC tumor reality, including CSCs, stromal component, and a biomimetic matrix, providing a new valuable research tool in precision oncology.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Cancer Cells and Metastasis · Circadian rhythm and melatonin · Spaceflight effects on biology

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (69)

Show source-provided references
1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries10.3322/caac.21660 ↗
2. Head and neck squamous cell carcinoma
3. A combined treatment with melatonin and andrographis promotes autophagy and anticancer activity in colorectal cancer10.1093/carcin/bgac008 ↗
4. Melatonin drives apoptosis in head and neck cancer by increasing mitochondrial ROS generated via reverse electron transport10.1111/jpi.12824 ↗
5. Intratumoral injection of melatonin enhances tumor regression in cell line-derived and patient-derived xenografts of head and neck cancer by increasing mitochondrial oxidative stress10.1016/j.biopha.2023.115518 ↗
6. Melatonin enhances cisplatin and radiation cytotoxicity in head and neck squamous cell carcinoma by stimulating mitochondrial ROS generation, apoptosis, and autophagy
7. The relationship between clock genes, Sirtuin 1, and mitochondrial activity in head and neck squamous cell cancer: effects of melatonin treatment10.3390/ijms241915030 ↗
8. Role of microenvironmental components in head and neck squamous cell carcinoma10.3390/jpm13111616 ↗
9. Cancer stem cell (CSC) resistance drivers10.1016/j.lfs.2019.116781 ↗
10. 3D bioprinted glioma stem cells for brain tumor model and applications of drug susceptibility10.1088/1758-5090/8/4/045005 ↗
11. Three dimensional cultivation increases chemo- and radioresistance of colorectal cancer cell lines10.1371/journal.pone.0244513 ↗
12. The biomimetic extracellular matrix: a therapeutic tool for breast cancer research10.1016/j.trsl.2021.11.008 ↗
13. Fibroblast-derived 3D matrix differentially regulates the growth and drug-responsiveness of human cancer cells10.1016/j.matbio.2008.02.008 ↗
14. Mesenchymal stem cell's secretome promotes selective enrichment of cancer stem-like cells with specific cytogenetic profile10.1016/j.canlet.2018.04.042 ↗
15. Melatonin targets metabolism in head and neck cancer cells by regulating mitochondrial structure and function10.3390/antiox10040603 ↗
16. Melatonin treatment normalizes plasma pro-inflammatory cytokines and nitrosative/oxidative stress in patients suffering from Duchenne muscular dystrophy10.1111/j.1600-079X.2010.00752.x ↗
17. Engineering of human skeletal muscle with an autologous deposited extracellular matrix10.3389/fphys.2018.01076 ↗
18. Cell-derived matrices for studying cell proliferation and directional migration in a complex 3D microenvironment10.1038/nprot.2017.107 ↗
19. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma10.1073/pnas.0610117104 ↗
20. Recent advances in the targeting of head and neck cancer stem cells10.3390/app132413293 ↗
21. CD98 marks a subpopulation of head and neck squamous cell carcinoma cells with stem cell properties10.1016/j.scr.2013.02.004 ↗
22. Estimation of clinical trial success rates and related parameters10.1093/biostatistics/kxx069 ↗
23. Models of head and neck squamous cell carcinoma using bioengineering approaches10.1016/j.critrevonc.2022.103724 ↗
24. Hoshiba, T. Decellularized extracellular matrix for cancer research. Mater. 2019, Vol. 12, Page 1311 2019, 12, 1311, doi:10.3390/MA12081311.10.3390/ma12081311 ↗
25. Fibroblast-derived matrix models desmoplastic properties and forms a prognostic signature in cancer progression10.3389/fimmu.2023.1154528 ↗
26. Fibroblast-derived extracellular matrices: an alternative cell culture System that increases metastatic cellular properties10.1371/journal.pone.0138065 ↗
27. The overexpression of fibronectin 1 promotes cancer progression and associated with M2 macrophages polarization in head and neck squamous cell carcinoma patients10.2147/IJGM.S364708 ↗
28. Fibronectin-guided migration of carcinoma collectives
29. Type I and III collagen degradation products in serum predict patient survival in head and neck squamous cell carcinoma10.1016/j.oraloncology.2011.09.002 ↗
30. Correlation between vascular endothelial growth factor pathway and immune microenvironment in head and neck squamous cell carcinoma10.1186/s12885-021-08547-4 ↗
31. Fibroblast growth factor receptors are components of autocrine signaling networks in head and neck squamous cell carcinoma cells10.1158/1078-0432.CCR-11-0050 ↗
32. Expression profiles of angiogenic growth factors in squamous cell carcinomas of the head and neck10.1002/ijc.11188 ↗
33. Three-dimensional collagen-based scaffold model to study the microenvironment and drug-resistance mechanisms of oropharyngeal squamous cell carcinomas10.20892/j.issn.2095-3941.2020.0482 ↗
34. Tumor microenvironment: an evil nexus promoting aggressive head and neck squamous cell carcinoma and avenue for targeted therapy
35. Targeting cancer stem cells as a strategy for reducing chemotherapy resistance in head and neck cancers10.1007/s00432-023-05136-9 ↗
36. The IL-6R and Bmi-1 axis controls self-renewal and chemoresistance of head and neck cancer stem cells10.1038/s41419-021-04268-5 ↗
37. EGFR enhances the stemness and progression of oral cancer through inhibiting autophagic degradation of SOX210.1002/cam4.2772 ↗
38. Cancer stem cell secretome in the tumor microenvironment: a key point for an effective personalized cancer treatment10.1186/s13045-020-00966-3 ↗
39. Bioprinted cancer-stromal in-vitro models in a decellularized ECM-based bioink exhibit progressive remodeling and maturation10.1088/1748-605X/acd830 ↗
40. Decellularized extracellular matrix composite hydrogel bioinks for the development of 3D bioprinted head and neck in vitro tumor models10.1021/acsbiomaterials.1c00812 ↗
41. Cancer stem cell (CSC) resistance drivers10.1016/j.lfs.2019.116781 ↗
42. In vitro models for head and neck cancer: current status and future perspective10.3389/fonc.2022.960340 ↗
43. Secretory autophagy in cancer-associated fibroblasts promotes head and neck cancer progression and offers a novel therapeutic target10.1158/0008-5472.CAN-17-1077 ↗
44. Single-cell transcriptome profiling of the stepwise progression of head and neck cancer
45. Cancer-associated fibroblast density, prognostic characteristics, and recurrence in head and neck squamous cell carcinoma: a meta-analysis10.3389/fonc.2020.565306 ↗
46. Zhao · 3D Co-culture of Cancer-Associated Fibroblast with Oral Cancer Organoids · 2020 · 201
47. Proteomic analysis of cancer-associated fibroblasts reveals a paracrine role for MFAP5 in human oral tongue squamous cell carcinoma10.1021/acs.jproteome.7b00925 ↗
48. Wnt signaling dynamics in head and neck squamous cell cancer tumor-stroma interactions10.1002/mc.22937 ↗
49. Factors secreted by cancer-associated fibroblasts that sustain cancer stem properties in head and neck squamous carcinoma cells as potential therapeutic targets10.3390/cancers10090334 ↗
50. Sensitivity to cisplatin in head and neck cancer cells is significantly affected by patient-derived cancer-associated fibroblasts10.3390/ijms22041912 ↗
51. Cancer-associated fibroblasts induce matrix metalloproteinase-mediated cetuximab resistance in head and neck squamous cell carcinoma cells10.1158/1541-7786.MCR-12-0030 ↗
52. TGF-Beta-Activated cancer-associated fibroblasts limit cetuximab efficacy in preclinical models of head and neck cancer10.3390/cancers12020339 ↗
53. Hakkinen · Direct Comparisons of the Morphology, Migration, Cell Adhesions, and Actin Cytoskeleton of Fibroblasts in Four Different Three-Dimensional Extracellular Matrices · 20100273
54. Use of melatonin in cancer treatment: where are we?
55. Melatonin inhibits the progression of oral squamous cell carcinoma via inducing miR-25-5p expression by directly targeting NEDD910.3389/fonc.2020.543591 ↗
56. Melatonin: emerging player in the management of oral cancer10.1615/CritRevOncog.2023048934 ↗
57. The potential therapeutic effect of melatonin on human ovarian cancer by inhibition of invasion and migration of cancer stem cells
58. Melatonin and its derivative disrupt cancer stem-like phenotypes of lung cancer cells via AKT downregulation10.1111/1440-1681.13572 ↗
59. Targeting cancer stem cells by melatonin: effective therapy for cancer treatment10.1016/j.prp.2020.152919 ↗
60. Melatonin inhibits the stemness of head and neck squamous cell carcinoma by modulating HA synthesis via the FOSL1/HAS3 axis10.1111/jpi.12940 ↗
61. Human tumor–derived matrix improves the predictability of head and neck cancer drug testing
62. Melatonin enhances cisplatin and radiation cytotoxicity in head and neck squamous cell carcinoma by stimulating mitochondrial ROS generation, apoptosis, and autophagy10.1155/2019/7187128 ↗
63. Combination of melatonin and rapamycin for head and neck cancer therapy: suppression of AKT/mTOR pathway activation, and activation of mitophagy and apoptosis via mitochondrial function regulation10.1111/jpi.12461 ↗
64. Dose-dependent proliferative and cytotoxic effects of melatonin on human epidermoid carcinoma and normal skin fibroblast cells10.1016/j.mrgentox.2018.04.002 ↗
65. Melatonin: the smart molecule that differentially modulates autophagy in tumor and normal placental cells10.1371/journal.pone.0202458 ↗
66. Utilizing melatonin to alleviate side effects of chemotherapy: a potentially good partner for treating cancer with ageing10.1155/2020/6841581 ↗
67. Evaluation of possible cytotoxic, genotoxic and epigenotoxic effects of titanium dioxide nanoparticles and possible protective effect of melatonin10.1080/15376516.2023.2259980 ↗
68. Antioxidants as precision weapons in war against cancer chemotherapy induced toxicity – exploring the armoury of obscurity10.1016/j.jsps.2017.12.013 ↗
69. Precision medicine gains momentum: novel 3D models and stem cell-based approaches in head and neck cancer10.3389/fcell.2021.666515 ↗